+380 57 717-73-96

EMBRyA Fol

INDICATIONS FOR USE

An additional source of folic acid and iodine, especially for women planning pregnancy, pregnant women and during lactation. Promotes overall strengthening of the body.

COMPOSITION

Folic acid – 0.2% (200.0 µg), L-methylfolate – 0.208% (equivalent to 200.0 µg folic acid), Potassium iodide – 0.262% (equivalent to 200.0 micrograms (µg) iodine). Auxiliary components: MCC – 50.0%, glucose – 46.33%, calcium stearate – 2.0%, aerosil – 1.0%.

DESCRIPTION OF ACTIVE SUBSTANCES

Folic acid is especially necessary at the very early stage of the origin of life, as well as during the period of growth and development of the human fetus – it takes part in hematopoiesis, ensures protein metabolism, RNA and DNA biosynthesis, which is important for growing tissues. Its deficiency leads to the accumulation of homocysteine in the blood plasma, which is an indicator of atherosclerotic changes. The absence of folic acid deficiency during pregnancy significantly reduces the risk of birth defects in the child (including neural tube defect, Spina bifida), malnutrition and prematurity.

more

APPLICATION

Take 1 tablet during breakfast at least 4 weeks before planned conception. Term of use of EMBRyA® Fol – minimum 12 weeks before conceiving.

If You have taken contraceptives and are planning pregnancy now, You should start taking EMBRyA® Fol as soon as You finish taking contraceptives.

CONTRAINDICATIONS

Individual sensitivity to certain components.

PRECAUTIONS

Patients with thyroidal disease or those taking other iodine preparations at doctor’s prescription and under medical supervision.

ENERGY VALUE KCAL / 100 G

180 kcal

NUTRITIONAL VALUE OF 100 G OF THE PRODUCT

Proteins – 0 g, fats – 0 g, carbohydrates – 45 g.

HOW SUPPLIED

0.1 g tablets №90; N150

SHELF LIFE

36 months